Paclitaxel (PanTher Therapeutics)

紫杉醇 (PanTher Therapeutics)

Report date: 2025/07/17 10:41:54

Base Information

Drug NamePaclitaxel (PanTher Therapeutics)
Drug Alias Namebiodegradable device containing 100mg of paclitaxelPTM-101
ClassificationSmall molecules > Heterocyclic drugsDrug and medical devices combination products
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPanTher Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPanTher Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A